This Week in Healthcare — Brussels (#29, 2026)
Commission approves €400m German State aid for insulin supply; Innovation Act proposed for healthcare R&D; Strategic procurement reform targets medical device access.
September 07, 2026 to September 13, 2026
Commission approves €400m German State aid for insulin supply; Innovation Act proposed for healthcare R&D; Strategic procurement reform targets medical device access.
📋 In This Week's Newsletter
• 🇪🇺 European Commission
• 📚 What We're Reading This Week
European Commission
Commission approves €400 million German State aid to enhance insulin supply resilience
On 7 September 2026, the European Commission approved a €400 million measure under EU State aid rules to strengthen the resilience of insulin supply in Germany. The aid, directed to Sanofi-Aventis Deutschland GmbH, is intended to compensate net costs for a service of general economic interest (SGEI), including constructing a new insulin factory at Frankfurt-Höchst by 31 December 2032, annual production targets, and stockpiling requirements until 2042. The measure prioritises EEA markets in the event of shortages and aims to address supply risks resulting from increasing production diversions. The Commission assessed the measure pursuant to Article 106(2) TFEU and the 2012 SGEI Framework, confirming that compensation is proportionate and arrangements are in place to prevent overcompensation. The decision aligns with the objectives of the Critical Medicines Act, proposed in March 2025, to boost domestic manufacturing and ensure essential medicines availability.
Commission proposes new European Innovation Act to accelerate healthcare research and procurement
On 8 September 2026, the Commission introduced the European Innovation Act, a key initiative under the EU Startup and Scaleup Strategy and Competitiveness Compass. The Act targets fragmented rules for innovators and aims to streamline access to financing, including through a common EU framework for intellectual property valuation. Healthcare and medical research sectors are expected to benefit from improved legal certainty for R&D procurement, facilitating joint cross-border projects and reducing administrative costs. The Act is projected to unlock €10.2 billion annually in financing for IP-backed ventures and generate €1 billion savings for public buyers. The proposal also includes a digital marketplace for IP transactions and support mechanisms within the European Union Intellectual Property Office.
Commission proposes simpler and more strategic Public Procurement rules impacting healthcare services and devices
On 8 September 2026, the Commission adopted a proposal for a new Public Procurement Regulation to modernise the EU's procurement framework. Coverage extends to healthcare infrastructure and services, consolidating three directives into a single regulation and reducing complexity across sector-specific legislation. The reform introduces three procedures, including an innovation procedure for novel medical solutions, and establishes a digital procurement marketplace to streamline participation and data exchanges. The Regulation sets quality criteria at a minimum of 30% weighting for contract awards, with higher thresholds for labour-intensive contracts, supporting strategic objectives such as resilience and security of supply. The proposal includes European preference mechanisms for critical sectors, including medicines, and will require negotiation by the European Parliament and Council before adoption.
Commission presents landmark India trade deal to Council for signature
On 10 September 2026, the Commission submitted proposals to the Council for the signing and conclusion of a Free Trade Agreement (FTA) with India. The FTA is expected to reduce tariffs on 96% of EU goods exports, including pharmaceuticals and medical devices, and save €4 billion annually in duties. The agreement, once ratified, will improve market access for European healthcare providers and manufacturers, facilitate investment, and support regulatory cooperation in healthcare and medical research. Commissioner Maroš Šefčovič emphasised the agreement's scale and its potential to create new opportunities in trade and innovation.
Press remarks by Vice-President Séjourné and Commissioner Zaharieva on Public Procurement Act and European Innovation Act
On 8 September 2026, Vice-President Stéphane Séjourné and Commissioner Ekaterina Zaharieva addressed the adoption of the Public Procurement Act and the European Innovation Act. Their remarks highlighted the impact on healthcare procurement, specifically the simplification of procedures and strategic use of public funds for medical devices and hospital infrastructure. The Innovation Act introduces a single rulebook for R&D procurement, with quality criteria constituting at least 50%, including a minimum 15% for innovation. The new procurement framework prioritises quality, security, and European preference, supporting critical medicine access and medical innovation. Regulatory sandboxes are recommended to accelerate deployment of new healthcare solutions.
Questions and answers on the European Innovation Act
On 8 September 2026, the Commission published a Q&A on the European Innovation Act, clarifying provisions for R&D procurement relevant to healthcare innovation. The Act establishes common rules for cross-border R&D procurement, legal certainty for public buyers, and EU preference for tenders. It addresses fragmentation in the procurement of innovative medical technologies and provides mechanisms for IP-backed finance and certification via the European Union Intellectual Property Office. Regulatory sandboxes are outlined as tools for controlled testing of medical products and digital health services, with safeguards for health and safety.
Questions and answers on the EU Public Procurement Act
On 8 September 2026, the Commission released a Q&A on the Public Procurement Act, detailing its impact on healthcare procurement. The Act replaces three directives with a single regulation, introduces a Digital Marketplace for procurement, and prioritises quality criteria for contract awards in health services and medical devices. Provisions facilitate SME participation and clarify environmental and social criteria, including accessibility and fair working conditions. The Act introduces innovation procedures for procurement of healthcare solutions and strengthens security, resilience, and European preference mechanisms for critical medicines.
What We're Reading This Week
- A matter of life and death: Researchers highlight urgent advancements needed to address critical gaps in medical care that directly impact patient survival rates.
- Video. Dogs trained to sniff out cancer with help from AI: AI-assisted canine detection offers promising new approach for early cancer diagnosis through enhanced scent identification.
- Getting mind ready for surgery is as important as physical preparation: Mental readiness before surgery can reduce anxiety, improve recovery, and lead to better overall surgical outcomes.
- Healthcare is driving Sweden's election: Big promises, few easy fixes: Political parties in Sweden propose ambitious healthcare reforms ahead of elections, but systemic challenges hinder quick solutions.
- In Sweden, despite anti-immigration rhetoric, public services still rely on foreign workers: Sweden’s essential public sectors remain dependent on immigrant labor, highlighting a gap between political rhetoric and workforce realities.
